8.250
+0,12%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1349.6% | +487.9% | 3 / 3 | +13.4% | -6.26 pp | +63.98 pp | +35.0% | 0.09 | 1.59 | 150 | +13,4% | 104 | +1.330,1% | 1.59 | 14.33 | −88,9% |
| Pts | 12 | 12 | 12 | 4 | 0 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 8.250 (close price on 2026-10-19)EPS (TTM): 5.178
Financial charts
1.Revenue & growth
VND bn150Q2/26
1.Revenue & growth
VND bn150Q2/26
2.Profit & growth
VND bn107Q2/26
3.Profit mix (Penman)
VND bn162Q2/26
4.Margins & cost structure
%25.4%Q2/26
5.Returns & cash cycle
% · days8.8%Q2/26
6.Earnings quality & cash
VND bn23,7Q2/26
7.Asset structure
VND bn616Q2/26
8.Funding & debt health
VND bn · times616Q2/26
9.Revenue backlog
VND bn0,72Q2/26
10.Valuation
times · %1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %4.354Q2/26
Adjusted EPS growth, latest quarter
14,8× higher
Average adjusted EPS growth, 3 quarters
699%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26